Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oxford Biomedica (OXB) Share Price

Price 610.00p on 14-04-2026 at 12:52:56
Change 38.00p 6.64%
Buy 611.00p
Sell 608.00p
Last Trade: Buy 179.00 at 611.00p
Day's Volume: 92,500
Last Close: 572.00p
Open: 579.00p
ISIN: GB00BDFBVT43
Day's Range 577.00p - 613.00p
52wk Range: 270.50p - 950.00p
Market Capitalisation: £737.49m
VWAP: 591.84218p
Shares in Issue: 120.90m

Oxford Biomedica (OXB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 179 611.00p SI Trade
13:52:56 - 14-Apr-26
Buy* 207 609.92p Ordinary
13:50:55 - 14-Apr-26
Buy* 76 610.00p Automatic Execution
13:48:49 - 14-Apr-26
Buy* 100 610.00p SI Trade
13:48:23 - 14-Apr-26
Buy* 5 610.00p Automatic Execution
13:47:24 - 14-Apr-26
Sell* 137 609.00p Automatic Execution
13:47:24 - 14-Apr-26
Sell* 9 610.00p Automatic Execution
13:47:24 - 14-Apr-26
Sell* 166 610.00p Automatic Execution
13:47:24 - 14-Apr-26
Sell* 311 610.00p Automatic Execution
13:47:24 - 14-Apr-26
Buy* 816 613.00p SI Trade
13:45:29 - 14-Apr-26
See more Oxford Biomedica trades

Oxford Biomedica (OXB) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Apr 2026 (Mon) 575.00 582.00 559.00 572.00 162,566
10th Apr 2026 (Fri) 561.00 581.00 561.00 566.00 241,867
9th Apr 2026 (Thu) 575.00 575.00 559.00 565.00 242,593
8th Apr 2026 (Wed) 551.00 586.00 550.00 574.00 213,259
7th Apr 2026 (Tue) 548.00 559.00 542.00 550.00 161,796
6th Apr 2026 (Mon) 560.00 560.00 560.00 560.00 0
3rd Apr 2026 (Fri) 560.00 560.00 560.00 560.00 0
2nd Apr 2026 (Thu) 556.00 563.00 544.00 560.00 196,460
1st Apr 2026 (Wed) 530.00 571.00 530.00 569.00 151,963
31st Mar 2026 (Tue) 566.00 566.00 542.00 545.00 181,134
30th Mar 2026 (Mon) 548.00 566.00 542.00 551.00 334,204
27th Mar 2026 (Fri) 568.00 570.00 559.00 561.00 329,929
26th Mar 2026 (Thu) 606.00 615.00 555.00 575.00 759,214
25th Mar 2026 (Wed) 580.00 608.00 580.00 606.00 402,105
24th Mar 2026 (Tue) 600.00 604.00 589.00 593.00 196,377
23rd Mar 2026 (Mon) 593.00 626.00 583.00 602.00 346,592
20th Mar 2026 (Fri) 613.00 626.00 601.00 617.00 654,479
19th Mar 2026 (Thu) 630.00 638.00 618.00 618.00 246,841
18th Mar 2026 (Wed) 630.00 661.00 630.00 644.00 538,383
17th Mar 2026 (Tue) 650.00 650.00 625.00 637.00 243,628
16th Mar 2026 (Mon) 642.00 642.00 625.00 633.00 93,494
See more Oxford Biomedica price history

Oxford Biomedica (OXB) Regulatory News

Date Source Headline
13th Apr 2026 7:00 am RNS-R Launch of viral vector fast-track offering
8th Apr 2026 5:18 pm RNS Grant of Awards
1st Apr 2026 7:00 am RNS Total Voting Rights
30th Mar 2026 3:30 pm RNS 2026 Annual General Meeting notification
26th Mar 2026 7:00 am RNS Preliminary results for the year ended 31 Dec 2025
18th Mar 2026 7:00 am RNS-R Licensing agreement with VVMF
9th Mar 2026 7:53 am RNS Admission to Trading
4th Mar 2026 11:45 am RNS Admission to Trading Application
3rd Mar 2026 7:00 am RNS Capital Markets Day and investor conferences
2nd Mar 2026 7:00 am RNS Total Voting Rights
See more Oxford Biomedica regulatory news

Oxford Biomedica (OXB) Share News

Oxford BioMedica accelerates viral vector development and manufacture

13th Apr 2026 10:54

(Alliance News) - Oxford Biomedica PLC on Monday announced the launch of fast-track offering for adeno-associated viral vectors and lentiviral vector platforms. Read More

WINNERS & LOSERS: Miners climb; Close Brothers down before FCA verdict

30th Mar 2026 09:47

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Monday. Read More

Oxford BioMedica shares fall as warns on loss-making first half

26th Mar 2026 12:07

(Alliance News) - Oxford BioMedica PLC on Thursday warned the first half of 2026 will be loss-making as the year will be skewed to the second half. Read More

LONDON BROKER RATINGS: Goldman raises Croda; Jefferies likes Diploma

23rd Mar 2026 09:01

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich

23rd Mar 2026 07:59

(Alliance News) - GSK makes regulatory progress in Japan for a cancer therapy, Anglo American moves to delist from the Swiss exchange as part of its restructuring, and Applied Nutrition reports strong interim growth while holding back on shareholder payouts. Read More

See more Oxford Biomedica news
FTSE 100 Latest
Value10,595.46
Change12.50

Login to your account

Forgot Password?

Not Registered